Related Experiment Video
Updated: Jul 28, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
The contribution of mosaicism to genetic diseases and de novo pathogenic variants
Rory J Tinker1, Lisa Bastarache2, Kimberly Ezell1
1Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abstract:
The contribution of mosaicism to diagnosed genetic disease and presumed de novo variants (DNV) is under investigated. We determined the contribution of mosaic genetic disease (MGD) and diagnosed parental mosaicism (PM) in parents of offspring with reported DNV (in the same variant) in the (1) Undiagnosed Diseases Network (UDN) (N = 1946) and (2) in 12,472 individuals electronic health records (EHR) who underwent genetic testing at an academic medical center. In the UDN, we found 4.51% of diagnosed probands had MGD, and 2.86% of parents of those with DNV exhibited PM. In the EHR, we found 6.03% and 2.99% and (of diagnosed probands) had MGD detected on chromosomal microarray and exome/genome sequencing, respectively. We found 2.34% (of those with a presumed pathogenic DNV) had a parent with PM for the variant. We detected mosaicism (regardless of pathogenicity) in 4.49% of genetic tests performed. We found a broad phenotypic spectrum of MGD with previously unknown phenotypic phenomena. MGD is highly heterogeneous and provides a significant contribution to genetic diseases. Further work is required to improve the diagnosis of MGD and investigate how PM contributes to DNV risk.
Insights
Mosaic genetic disease (MGD) is a significant cause of genetic disorders, affecting over 4% of individuals. Parental mosaicism (PM) also contributes to presumed de novo variants (DNVs), highlighting the need for better MGD diagnosis.
Area of Science:
- Genetics
- Genomic Medicine
- Clinical Diagnostics
Background:
- Mosaicism, where an individual has cell populations with different genetic makeup, is understudied in diagnosed genetic diseases.
- Presumed de novo variants (DNVs) in offspring are often assumed to originate newly, but parental mosaicism (PM) is an alternative explanation.
- Understanding the prevalence and impact of mosaic genetic disease (MGD) and PM is crucial for accurate genetic diagnosis.
Purpose of the Study:
- To determine the contribution of MGD and PM to genetic diseases and DNVs.
- To investigate the prevalence of MGD in diagnosed probands and PM in parents of offspring with DNVs.
- To characterize the phenotypic spectrum associated with MGD.
Main Methods:
- Analysis of data from the Undiagnosed Diseases Network (UDN) cohort (N=1946).
- Evaluation of electronic health records (EHR) from 12,472 individuals undergoing genetic testing.
- Detection of mosaicism using chromosomal microarray and exome/genome sequencing.
Main Results:
- MGD was diagnosed in 4.51% of UDN probands and in 6.03% (chromosomal microarray) and 2.99% (exome/genome sequencing) of EHR probands.
- PM was identified in 2.86% of parents with offspring having DNVs in the UDN and in 2.34% of parents with presumed pathogenic DNVs in the EHR cohort.
- Mosaicism was detected in 4.49% of all genetic tests performed, revealing a broad phenotypic spectrum of MGD.
Conclusions:
- Mosaic genetic disease is a significant and heterogeneous contributor to diagnosed genetic disorders.
- Parental mosaicism plays a role in the occurrence of presumed de novo variants, necessitating further investigation.
- Improved diagnostic approaches for MGD and a deeper understanding of PM's contribution to DNV risk are required.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genome Copying Errors
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Gene Conversion

